Literature DB >> 166922

Inhibition of Herpesvirus hominis replication by human interferon.

L Rasmussen, L B Farley.   

Abstract

The effect of human interferon on single-cycle replication of Herpesvirus hominis type 1 (HV-1) and vesicular stomatitis virus (VSV) in human foreskin fibroblast cultures (HFF) was studied. After treatment of HFF cultures with low concentrations (58 U) of human interferon, a variable but statistically significant inhibition of HV-1 was observed. At higher concentrations (greater than 95 U) yield reduction of HV in interferon-treated cultures approached that of VSV. Preliminary data indicate that antiviral activity decays more rapidly for HV-1 than for VSV after removal of interferon from cultures.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166922      PMCID: PMC415252          DOI: 10.1128/iai.12.1.104-108.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Further studies on an inhibitor of viral activity appearing in infected cell cultures and its role in chronic viral infections.

Authors:  M HO; J F ENDERS
Journal:  Virology       Date:  1959-11       Impact factor: 3.616

2.  Interferon and cytomegalovirus in vivo and in vitro.

Authors:  L A Glasgow; J B Hanshaw; T C Merigan; J K Petralli
Journal:  Proc Soc Exp Biol Med       Date:  1967-07

3.  Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.

Authors:  G W Jordan; R P Fried; T C Merigan
Journal:  J Infect Dis       Date:  1974-07       Impact factor: 5.226

4.  Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures.

Authors:  J S Youngner; H R Thacore; M E Kelly
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

5.  Sensitivity of human conjunctival tissue cultures to adenovirus 8, herpes simplex and vaccinia viruses. Induction of resistance by an interferon inducer.

Authors:  M Weissenbacher; E Chowchuvech; G Schmunis; L Sawicki; M A Galin
Journal:  Proc Soc Exp Biol Med       Date:  1973-03

6.  [Protection by interferon of human embryo cells against infection by cytomegalic virus].

Authors:  M T Thomas; I Gresser
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1969-06-23

7.  Interference mediated by a variant of Sindbis virus. I. Isolation of an avirulent variant and in vivo interference.

Authors:  L E Rasmussen; J A Armstrong; M Ho
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

8.  Concerning the mechanism of action of interferon.

Authors:  W K Joklik; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

9.  Factors affecting the sensitivity of different viruses to interferon.

Authors:  J V Hallum; H R Thacore; J S Youngner
Journal:  J Virol       Date:  1970-08       Impact factor: 5.103

  9 in total
  13 in total

1.  Susceptibility of human lymphocyte populations to infection by herpes simplex virus.

Authors:  B K Pelton; R C Imrie; A M Denman
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

2.  Effect of recombinant mouse interferon-beta on acute and latent herpes simplex infection in mice.

Authors:  M Yamada; Y Arao; A Hatano; F Uno; S Nii
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Sensitivity in vitro of herpes simplex virus isolates to human fibroblast interferon.

Authors:  S Leventon-Kriss; M Movshovitz; Z Smetana; M Shewach-Millet; T Doerner; T Gotlieb-Stematsky
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

4.  Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2.

Authors:  T L Stanwick; R F Schinazi; D E Campbell; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

5.  Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon.

Authors:  M J Levin; P L Leary
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  Susceptibility of bovine macrophages to infectious bovine rhinotracheitis virus infection.

Authors:  A J Forman; L A Babiuk; V Misra; F Baldwin
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

7.  Response of cloned progeny of clinical isolates of herpes simplex virus to human leukocyte interferon.

Authors:  R Lazar; M K Breinig; J A Armstrong; M Ho
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  Effect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells.

Authors:  M J Levin; P L Leary; R D Arbeit
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

9.  Effect of cyclic AMP and cyclic GMP on the activity of interferon against herpes simplex virus types 1 and 2, and vesicular stomatitis virus.

Authors:  T L Stanwick; A J Nahmias
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

10.  Interferon susceptibility of herpes simplex virus strains isolated from patients enrolled in clinical trials.

Authors:  J A Armstrong; M B Skicki-Mullen; M K Breinig; M Ho
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.